Ding ZN - Search Results

1

Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis.

Yan LJ, Yao SY, Meng GX, Liu KX, Li HC, Ding ZN, Dong ZR, Hong JG, Chen ZQ, Li T. Yan LJ, et al. Among authors: ding zn. Hepatol Int. 2021 Dec;15(6):1413-1420. doi: 10.1007/s12072-021-10249-9. Epub 2021 Sep 3. Hepatol Int. 2021. PMID: 34478116

2

Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis.

Ding ZN, Dong ZR, Chen ZQ, Yang YF, Yan LJ, Li HC, Liu KX, Yao CY, Yan YC, Yang CC, Li T. Ding ZN, et al. J Gastroenterol Hepatol. 2021 Jun;36(6):1487-1496. doi: 10.1111/jgh.15395. Epub 2021 Jan 26. J Gastroenterol Hepatol. 2021. PMID: 33393670

3

RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival.

Dong ZR, Chen ZQ, Yang XY, Ding ZN, Liu KX, Yan LJ, Meng GX, Yang YF, Yan YC, Yao SY, Yang CC, Zhi XT, Li T. Dong ZR, et al. Among authors: ding zn. J Cancer. 2021 May 5;12(13):3827-3840. doi: 10.7150/jca.56167. eCollection 2021. J Cancer. 2021. PMID: 34093791 Free PMC article.

4

Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis.

Ding Z, Dong Z, Chen Z, Hong J, Yan L, Li H, Yao S, Yan Y, Yang Y, Yang C, Li T. Ding Z, et al. Front Immunol. 2021 Sep 29;12:733530. doi: 10.3389/fimmu.2021.733530. eCollection 2021. Front Immunol. 2021. PMID: 34659220 Free PMC article.

5

Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.

Xue JS, Liu H, Meng GX, Ding ZN, Yan LJ, Yao SY, Li HC, Dong ZR, Chen ZQ, Hong JG, Li T. Xue JS, et al. Among authors: ding zn. Cancer Immunol Immunother. 2022 Jul;71(7):1633-1644. doi: 10.1007/s00262-021-03103-2. Epub 2021 Nov 8. Cancer Immunol Immunother. 2022. PMID: 34750662 Free PMC article.

6

Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies.

Yan YC, Meng GX, Ding ZN, Liu YF, Chen ZQ, Yan LJ, Yang YF, Liu H, Yang CC, Dong ZR, Hong JG, Li T. Yan YC, et al. Among authors: ding zn. J Cancer. 2022 Jan 1;13(1):88-101. doi: 10.7150/jca.65574. eCollection 2022. J Cancer. 2022. PMID: 34976173 Free PMC article.

7

The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.

Han CL, Meng GX, Ding ZN, Dong ZR, Chen ZQ, Hong JG, Yan LJ, Liu H, Tian BW, Yang LS, Xue JS, Li T. Han CL, et al. Among authors: ding zn. Front Immunol. 2022 Feb 8;13:827788. doi: 10.3389/fimmu.2022.827788. eCollection 2022. Front Immunol. 2022. PMID: 35211122 Free PMC article.

8

Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease.

Hong JG, Yan LJ, Li X, Yao SY, Su P, Li HC, Ding ZN, Wang DX, Dong ZR, Li T. Hong JG, et al. Among authors: ding zn. World J Gastroenterol. 2022 Feb 14;28(6):689-692. doi: 10.3748/wjg.v28.i6.689. World J Gastroenterol. 2022. PMID: 35317426 Free PMC article.

9

The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Xue JS, Ding ZN, Meng GX, Yan LJ, Liu H, Li HC, Yao SY, Tian BW, Dong ZR, Chen ZQ, Hong JG, Wang DX, Li T. Xue JS, et al. Among authors: ding zn. Front Immunol. 2022 Apr 7;13:872353. doi: 10.3389/fimmu.2022.872353. eCollection 2022. Front Immunol. 2022. PMID: 35464489 Free PMC article.

10

Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades.

Han CL, Yan YC, Yan LJ, Meng GX, Yang CC, Liu H, Ding ZN, Dong ZR, Hong JG, Chen ZQ, Li T. Han CL, et al. Among authors: ding zn. J Cancer Res Clin Oncol. 2023 Apr;149(4):1425-1441. doi: 10.1007/s00432-022-04008-y. Epub 2022 Apr 28. J Cancer Res Clin Oncol. 2023. PMID: 35482077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters